{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:14:50Z","timestamp":1760908490568},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.ijrobp.2008.12.026","type":"journal-article","created":{"date-parts":[[2009,5,9]],"date-time":"2009-05-09T08:18:43Z","timestamp":1241857123000},"page":"1181-1186","source":"Crossref","is-referenced-by-count":8,"title":["Hyperfractionated Low-Dose (21 Gy) Radiotherapy for Cranial Skeletal Metastases in Patients With High-Risk Neuroblastoma"],"prefix":"10.1016","volume":"75","author":[{"given":"Brian H.","family":"Kushner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nai-Kong V.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shakeel","family":"Modak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karima","family":"Yataghene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne L.","family":"Wolden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2008.12.026_bib1","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/0959-8049(92)90062-7","article-title":"High-dose rapid schedule chemotherapy for disseminated neuroblastoma","volume":"28A","author":"Pearson","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib2","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1200\/JCO.2004.02.101","article-title":"Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma","volume":"22","author":"Kushner","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib3","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJM199910143411601","article-title":"Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid","volume":"341","author":"Matthay","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib4","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1200\/JCO.1998.16.9.3053","article-title":"Anti-GD2 antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age","volume":"16","author":"Cheung","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib5","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1200\/JCO.2001.19.11.2821","article-title":"Hyperfractionated low-dose (21 Gy) radiotherapy for high-risk neuroblastoma following intensive chemotherapy and surgery","volume":"19","author":"Kushner","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0360-3016(02)04506-6","article-title":"Impact of radiotherapy for high-risk neuroblastoma: A Children's Cancer Group study","volume":"56","author":"Hans-Kogan","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib7","first-page":"62","article-title":"[Increased incidence of skull metastases in neuroblastoma]","volume":"66","author":"Alberts","year":"1984","journal-title":"S Afr Med J"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib8","first-page":"1723","article-title":"Bone metastasis of malignant solid tumors in childhood","volume":"14","author":"Taguchi","year":"1987","journal-title":"Jpn J Cancer Chemother"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00043426-199905000-00005","article-title":"Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival","volume":"21","author":"DuBois","year":"1999","journal-title":"J Pediatr Hematol\/Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib10","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/1097-0142(19830901)52:5<915::AID-CNCR2820520529>3.0.CO;2-7","article-title":"Nonrandom distribution of metastases in neuroblastic tumors","volume":"52","author":"de la Monte","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/bmj.1.4435.31-a","article-title":"On suprarenal sarcoma in children with metastases in the skull","volume":"1","author":"Hutchinson","year":"1907","journal-title":"Q J Med"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib12","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/(SICI)1097-0142(19971115)80:10<1997::AID-CNCR18>3.0.CO;2-T","article-title":"Blindness in children with neuroblastoma","volume":"80","author":"Belgaumi","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib13","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/pbc.21384","article-title":"Brain-sparing radiotherapy for neuroblastoma skull metastases","volume":"50","author":"Wolden","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib14","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1200\/JCO.1993.11.8.1466","article-title":"Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment","volume":"11","author":"Brodeur","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2307\/2530374","article-title":"The analysis of failure time data in the presence of competing risks","volume":"34","author":"Prentice","year":"1978","journal-title":"Biometrics"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib17","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2001.19.22.4189","article-title":"Phase II trial of the anti-GD2 monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma","volume":"19","author":"Kushner","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/1096-911X(20010101)36:1<227::AID-MPO1055>3.0.CO;2-U","article-title":"N7: A novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age","volume":"36","author":"Cheung","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/cncr.22004","article-title":"Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma","volume":"107","author":"Kushner","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib20","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/0360-3016(86)90326-3","article-title":"Radiation therapy in the management of neuroblastoma: The Duke University Medical Center experience 1967\u20131984","volume":"12","author":"Halperin","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1200\/JCO.1984.2.7.719","article-title":"Neuroblastoma: The Joint Center for Radiation Therapy\/Dana-Farber Cancer Institute\/Children's Hospital experience","volume":"2","author":"Rosen","year":"1984","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0167-8140(85)80029-3","article-title":"The radiobiology of human neuroblastoma","volume":"3","author":"Deacon","year":"1985","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0167-8140(86)80199-2","article-title":"Radiobiological considerations in the treatment of neuroblastoma by total body irradiation","volume":"6","author":"Wheldon","year":"1986","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0360-3016(82)90517-X","article-title":"Changes in early and late radiation responses with altered fractionation: Implications for dose\u2013survival relationships","volume":"8","author":"Thames","year":"1982","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0360-3016(94)90144-9","article-title":"Radiation induced height impairment in pediatric Hodgkin's disease","volume":"28","author":"Willman","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib26","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1200\/JCO.1993.11.11.2226","article-title":"Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: A Children's Cancer Group pilot study","volume":"11","author":"Matthay","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib27","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/0360-3016(95)00011-M","article-title":"Patterns of failure following total body irradiation and bone marrow transplantation with or without a radiotherapy boost for advanced neuroblastoma","volume":"32","author":"Sibley","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/08880010390158504","article-title":"Relapse in the skull after myeloablative therapy for high-risk neuroblastoma","volume":"20","author":"Sangthawan","year":"2003","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib29","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1200\/JCO.2003.07.142","article-title":"Impact of MIBG scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy","volume":"21","author":"Kushner","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib30","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1200\/JCO.1998.16.12.3880","article-title":"Neuroblastoma and treatment-related myelodysplasia\/leukemia: The Memorial Sloan-Kettering experience and a literature review","volume":"16","author":"Kushner","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib31","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/pbc.20331","article-title":"Long-term complications in survivors of advanced stage neuroblastoma","volume":"45","author":"Lavardiere","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib32","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0959-8049(97)00281-5","article-title":"Survival from non-stage 4 neuroblastoma without cytotoxic therapy: An analysis of clinical and biological markers","volume":"33","author":"Cheung","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00043426-200401000-00012","article-title":"Radically different treatment recommendations for newly diagnosed neuroblastoma: Pitfalls in assessment of risk","volume":"26","author":"Kushner","year":"2004","journal-title":"J Pediatr Hematol\/Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.026_bib34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/pbc.20564","article-title":"Liver involvement in neuroblastoma: The Memorial Sloan-Kettering experience supports treatment reduction in young patients","volume":"46","author":"Kushner","year":"2006","journal-title":"Pediatr Blood Cancer"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030160803928X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030160803928X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T02:20:03Z","timestamp":1545272403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030160803928X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S036030160803928X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2008.12.026","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}